Rathbones Group PLC Q4 2024 Filing
Filed February 13, 2025
Portfolio Value
$20.7B
Holdings
609
Report Date
Q4 2024
Filing Type
13F-HR
All Holdings (609 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 601 | UREUR ENERGY INC NPV Common Stock | 20,000 | $22.8M | 0.11% | |
| 602 | LCTXLineage Cell Thera COM Npv | 35,000 | $17.6M | 0.09% | |
| 603 | EMXEMX Royalty Corp COM Npv | 10,000 | $17.4M | 0.08% | |
| 604 | OTLYOATLY GROUP AB Spon ADS Ea Rep 1 Ord Share | 11,232 | $7.4M | 0.04% | |
| 605 | CARAEURCARA THERAPEUTICS INC USD0.001 Common Stock | 20,164 | $7.2M | 0.03% | |
| 606 | —Bioline Rx Ltd Spon ADR Each Rep 15 Ord Sh | 31,666 | $6.8M | 0.03% | |
| 607 | IPA1GBPIMMUNOPRECISE ANTIBODIES LTD NPV Com Stock (Post Rev Split) | 14,000 | $5.8M | 0.03% | |
| 608 | TRXTRX Gold Corp COM Npv | 14,000 | $4.3M | 0.02% | |
| 609 | AUMNGOLDEN MINERALS CO USD0.01 Com Stock (P/R Split) | 20,289 | $1.9M | 0.01% |
PreviousPage 7 of 7